Invivyd, Inc.

Healthcare

NASDAQ:IVVD · NASDAQ Global Market

Market Cap $128.73M Beta 0.63 P/E (TTM) -3.9

$0.97 +4.16%

+$0.04 today

52W Low $0.48High $3.07

Vol 14.12M · Avg 3.62M

EPS (TTM) -$0.25Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+38.32%

Period High

$2.88

Period Low

$0.52

Latest

$0.97

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

SELLAS Life Sciences Group, Inc.

NASDAQ:SLS

$1.17B

Genfit S.A.

GNFT

$445.68M

C4 Therapeutics, Inc.

NASDAQ:CCCC

$334.23M

OmniAb, Inc.

NASDAQ:OABI

$259.52M

Orchestra BioMed Holdings, Inc.

NASDAQ:OBIO

$233.54M

Codexis, Inc.

NASDAQ:CDXS

$225.88M

Protara Therapeutics, Inc.

NASDAQ:TARA

$154.55M

Insight Molecular Diagnostics Inc.

NASDAQ:IMDX

$146.29M

Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

$99.38M

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

$72.83M

What is the latest IVVD filing?

The latest filing shown is 4 dated May 21, 2026.

How many recent filings does IVVD have?

Intrinsic Alpha currently shows 20 recent filings for IVVD.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.